Geode Capital Management
DMTX

Geode Capital Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Geode Capital Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-119,291
Closed -$715K – 4132
2017
Q3 		$715K Hold
119,291
– – ﹤0.01% 3240
2017
Q2 		$172K Sell
119,291
-26,605
-18% -$36.2K ﹤0.01% 3734
2017
Q1 		$255K Buy
145,896
+9,946
+7% +$26.4K ﹤0.01% 3567
2016
Q4 		$591K Buy
135,950
+196
+0.1% +$1.04K ﹤0.01% 3209
2016
Q3 		$1.08M Buy
135,754
+75,823
+127% +$548K ﹤0.01% 2903
2016
Q2 		$359K Buy
59,931
+867
+1% +$6.6K ﹤0.01% 3362
2016
Q1 		$462K Buy
+59,064
New +$465K ﹤0.01% 3272

Geode Capital Management's DMTX Position: Q4 2017 in Review

Geode Capital Management sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 119,291 shares — an estimated $715K sold.

Geode Capital Management first reported a position in DMTX in Q1 2016 and held it in 7 quarters. The position peaked at $1.08M in Q3 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

  • Geode Capital Management reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Geode Capital Management sold 119,291 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $715K.
  • Geode Capital Management first reported a position in Dimension Therapeutics, Inc in Q1 2016 and held it in 7 quarters.
  • Geode Capital Management's Dimension Therapeutics, Inc position peaked at $1.08M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.